Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells
- 8 March 2009
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 275 (1), 86-92
- https://doi.org/10.1016/j.canlet.2008.10.001
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate CancerCancer Research, 2008
- Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallateInternational Journal of Cancer, 2004
- The Adrenal Androgen Androstenediol Is Present in Prostate Cancer Tissue after Androgen Deprivation Therapy and Activates Mutated Androgen ReceptorCancer Research, 2004
- Molecular pathway for (−)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cellsArchives of Biochemistry and Biophysics, 2002
- Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenolsProceedings of the National Academy of Sciences of the United States of America, 2001
- Green tea: Biochemical and biological basis for health benefitsVitamins and Hormones, 2001
- Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cellsOncogene, 2000
- Modulation of Endocrine Systems and Food Intake by Green Tea Epigallocatechin Gallate*Endocrinology, 2000
- PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates.Proceedings of the National Academy of Sciences of the United States of America, 1994
- DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled waterAnalytical Biochemistry, 1990